FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing
This article was originally published in The Tan Sheet
Executive Summary
FDA's pediatric and nonprescription drugs advisory committees will consider whether the agency should add dosing information for children under 2 years to labels for OTC products containing acetaminophen at a joint meeting May 17-18.